Hh sequestration decreases wing size in both species and relative eyespot size in <i>J. coenia</i>. by Xiaoling Tong (141534)

Scatter plot of the decrease in the average number of interactions after eliminating the proteins with the corresponding keyword, and the number of eliminated entries. by Motonori Ota (3064)

Metal-reactive lymphocytes from individuals’ exhibit significant decreased metal-reactivity in the presence of inflammasome based inhibitors. by Lauryn Samelko (424639)

Effect of ex vivo treatment with rhTGFβ1 or a TGFβ1 inhibitor on monocyte responses to rgE stimulation. Monocytes and NK cells purified from PBMC collected from 10 RZV recipients (... by Michael J. Johnson (5818168)

A comparative study of the toxicological aspects of vanadium pentoxide and vanadium oxide nanoparticles by Apoorva Kulkarni (1287453)

“…V₂O₅ and VO₂ NPs exhibited rod and spherical symmetry, respectively with a mean diameter of 50 ± 20 and 30 ± 10 nm. …”

CB₁R activity increases while DOR activity decreases in cortex of lesioned animals. by Ittai Bushlin (191060)

A decreased response to yeast odorant attractant is observed in <i>sema1a</i> knockdown animals. by Keshava Mysore (413368)

Liability threshold model for nsCL/P. by Laurence J. Howe (5579186)

Pdl1 and Orf53 expression in strain W14 increases and decreases Tc toxin release respectively. by Guowei Yang (163967)

miR-155 over-expression in primary macrophages and cell lines decreases their susceptibility to HIV-1 infection. by Gokul Swaminathan (134124)

Presence of stromal cells decreased the cytotoxic effect of SH-4-54 on GBAM1 in 3D culture. by R. Marisol Herrera-Perez (4993793)

Image_1_Decrease in Serum Urate Level Is Associated With Loss of Visceral Fat in Male Gout Patients.tif by Zijing Ran (11429935)

“…</p>Results<p>ULT resulted in a mean (standard deviation) decrease in SU level (464.22 ± 110.21 μmol/L at baseline, 360.93 ± 91.66 μmol/L at the final visit, p <0.001) accompanied by a decrease in median (interquartile range) VFA [97.30 (81.15–118.55) at baseline, 90.90 (75.85–110.05) at the final visit, p < 0.001]. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Overtrained mice show dichotomous modulation of timing-dependent synaptic depression (tLTD) in response to a change in the prevailing A–O contingency. by Vincent Paget-Blanc (21807763)

Data_Sheet_1_Grape polyphenols decrease circulating branched chain amino acids in overfed adults.pdf by Simona Bartova (14011194)

Deciphering Nonbioavailable Substructures Improves the Bioavailability of Antidepressants by Serotonin Transporter by Zhi-Zheng Wang (6056033)

“…Here, we proposed the concept of “nonbioavailable substructures”, referring to substructures that are unfavorable to bioavailability. …”